Aditxt, Inc. Selling, General and Administrative Expense
Aditxt, Inc. (ADTX) reported Selling, General and Administrative Expense of $1.85 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-04-17
- Aditxt, Inc. selling, general and administrative expense for the quarter ending 2022-06-30 was $833.94K, a 1797.78% increase year-over-year.
- Aditxt, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $86.60K, a 47.87% increase year-over-year.
- Aditxt, Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $82.42K, a 11.16% increase year-over-year.
- Aditxt, Inc. selling, general and administrative expense for the quarter ending 2021-09-30 was $150.06K, a 2901.12% increase year-over-year.
- Aditxt, Inc. selling, general and administrative expense for fiscal 2022 was $1.85M, a 452.12% increase from fiscal 2021.
- Aditxt, Inc. selling, general and administrative expense for fiscal 2021 was $334.98K, a 308.57% increase from fiscal 2020.
- Aditxt, Inc. selling, general and administrative expense for fiscal 2020 was $81.99K, a 14779.67% increase from fiscal 2019.
- Aditxt, Inc. selling, general and administrative expense for fiscal 2019 was $551.00.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.85M 10-K · filed 2023-04-17 | |||
| 2022-06-30 | $833.94K 10-Q · filed 2022-08-15 | $920.54K 10-Q · filed 2022-08-15 | $1.00M derived: sum of 3 quarters · filed 2023-04-17 | $1.15M derived: sum of 4 quarters · filed 2023-04-17 |
| 2022-03-31 | $86.60K 10-Q · filed 2022-05-16 | $169.01K derived: sum of 2 quarters · filed 2023-04-17 | $319.07K derived: sum of 3 quarters · filed 2023-04-17 | $363.01K derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-12-31 | $82.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $232.47K derived: sum of 2 quarters · filed 2023-04-17 | $276.41K derived: sum of 3 quarters · filed 2023-04-17 | $334.98K 10-K · filed 2023-04-17 |
| 2021-09-30 | $150.06K 10-Q · filed 2021-11-15 | $194.00K derived: sum of 2 quarters · filed 2022-08-15 | $252.56K 10-Q · filed 2021-11-15 | $326.70K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | $43.94K 10-Q · filed 2022-08-15 | $102.51K 10-Q · filed 2022-08-15 | $176.65K derived: sum of 3 quarters · filed 2022-08-15 | $181.65K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $58.56K 10-Q · filed 2022-05-16 | $132.70K derived: sum of 2 quarters · filed 2022-05-16 | $137.70K derived: sum of 3 quarters · filed 2022-05-16 | $140.55K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $74.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $79.14K derived: sum of 2 quarters · filed 2022-03-31 | $81.99K derived: sum of 3 quarters · filed 2022-03-31 | $81.99K 10-K · filed 2022-03-31 |
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-15 | $7.85K derived: sum of 2 quarters · filed 2021-11-15 | $7.85K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $2.85K 10-Q · filed 2021-08-12 | $2.85K 10-Q · filed 2021-08-12 | ||
| 2019-12-31 | $404.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $404.00 derived: sum of 2 quarters · filed 2021-03-25 | $513.00 derived: sum of 3 quarters · filed 2021-03-25 | $551.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $109.00 derived: sum of 2 quarters · filed 2020-11-13 | $147.00 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $109.00 10-Q · filed 2020-08-13 | $147.00 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |